Leestip van de redactie: Depressie tijdens menopauze: EMAS position statement
22 januari 2020
Recentelijk is in Maturitas het EMAS position statement gepubliceerd over het management van depressieve symptomen bij peri- en postmenopauzale vrouwen.
De belangrijkste punten uit de position statement paper samengevat:
- •The perimenopause is considered to be a time of increased risk for the development of depressive symptoms and major depressive episodes.
- •Depression awareness, detection, diagnostics, personalized treatment and a suitable follow-up schedule need to be integrated worldwide.
- •Treatment comprises antidepressants, psychosocial therapies and lifestyle changes.
- •Although not approved for this indication, menopausal hormone therapy may improve depressive symptoms in peri- but not in postmenopausal women.
- •A stronger evidence base is needed for the use of alternative and complementary therapies.
een link naar het artikel vindt u hier
De Menopauze Specialist
Actuele richtlijnen
Richtlijn management rondom de menopauze
NAMS position statement
NICE guidelines - gynecological conditions
Global Consensus statement on Menopausal Hormone Therapy
European Menopause and Andropause Society
International Menopause Society
EMAS position statement menopause in the workplace
EMAS Position Paper Menopause 2022
Volg ons op
Copyright © 2016 - 2022 De Menopauze Specialist | Privacyverklaring | Cookie verklaring